Nevro Corp at JPMorgan Healthcare Conference Transcript
Morning, everyone. Welcome to the final day of the JPMorgan Healthcare Conference. My name is Allen Gong on the medical supplies and devices team really excited to be introducing the management team of never today.
We're going to start off with prepared remarks from CEO, Kevin Varin, all before moving to an open Q&A with the broader management team from the sorry, appreciate it.
Thanks, everybody, for your interest in the Company.
Obviously, the first page forward looking statements, please make it a chance to look over those.
And we may talk about non-GAAP financial measures which you can read on this slide as well.
So whenever we have a unique value proposition, we have multiple growth drivers in a very large and diversified spinal cord stimulation market and we have new indications, not only that we have today, but also new indications coming for use of neuromodulation in the spinal cord for different disease
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
